UK Markets close in 7 hrs 4 mins

Why Editas Medicine Stock Is Getting Crushed Today

Prosper Junior Bakiny, The Motley Fool
·2-min read
Why Editas Medicine Stock Is Getting Crushed Today
  • Oops!
    Something went wrong.
    Please try again later.

Shares of gene-editing specialist Editas Medicine (NASDAQ: EDIT) are falling sharply on Friday and were down by 16.7% as of 2:02 p.m. EDT. Goldman Sachs analyst Madhu Kumar initiated coverage of Editas Medicine with a sell rating Friday. Editas Medicine's share price as of the closing of business day yesterday was $40.98.